Live Breaking News & Updates on ஆரோக்கியம் ப்ராடக்ட்ஸ் இயக்குநரகம்

Stay updated with breaking news from ஆரோக்கியம் ப்ராடக்ட்ஸ் இயக்குநரகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: Quarterly Results

Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: Quarterly Results
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Western Australia , City Of , Republic Of Ireland , Pharma Cognicann , Tmand Cannepil , David Lim , Tim Pearson , Turner Pope , Roby Zomer , Andy Thacker , Nadya Lisodover , Contract Sales Team Agreement , Australian Taxation Office , Menarini Group , Cannabis Access Program , Ethics Committee , Opportunity Fund , National Product Number , Health Products Directorate , Republic Of Ireland Health Service Executive , Corporate Governance Council Principles , Disclosure Committee , Swinburne University Of Technology , Company Malta ,

Glow LifeTech Reports on Additional Research Results on ArtemiC and

Article content
The results, announced on May 7, 2021, demonstrate the mechanism of action of ArtemiC™ is to reduce inflammation and suppress the cytokine storm
2 – believed to be the one of the leading causes of mortality in COVID-19 patients
3. The results show that ArtemiC™ decreases the markers of inflammation (IFN-g, IL-1a and TNF-a), in the bronchoalveolar lavage fluid (BALF) of mice in the animal model of cytokine storm related to COVID-19. The clinical and preclinical results to date support ArtemiC™ being effective for addressing cytokine overproduction which is found in different variants and mutations of COVID-19.
“ArtemiC™ focuses on preventing and reducing the severity of the cytokine storm and hyper-inflammation induced by respiratory viruses, and since all current COVID-19 variants of concern may lead to a cytokine storm, the preclinical and clinical results support that ArtemiC™ should be effective on COVID-19 variants,” said Tom Gl ....

Rob Carducci , Tom Glawdel , Glow Lifetech Ltd , Glow Lifetech Corp , Pharmaceuticals Ltd , Newsfile Corp , Health Canada Natural , Mycell Technology , Micelle Technology , Swiss Pharmacan Ag Micelle Technology , Placebo Group , Health Canada , Health Products Directorate , Glow Lifetech Reports , Additional Research Results , Positive Implications , Glow Lifetech , Chief Operating Officer , Chief Commercial Officer , Non Prescription Health Products Directorate , Swiss Pharmacan , கொள்ளை கார்டுக்ஸி , பளபளப்பு ஆயுட்காலம் லிமிடெட் , பளபளப்பு ஆயுட்காலம் கார்ப் , மருந்துகள் லிமிடெட் , ஆரோக்கியம் கனடா இயற்கை ,

Glow LifeTech Announces Successful First Commercial Production of ArtemiC(TM) for Global Distributor and a Second Production Scaled to Meet Growing Global Demand

Glow LifeTech Announces Successful First Commercial Production of ArtemiC(TM) for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , W Clark Kent , Rob Carducci , Tom Glawdel , Bernhard Langer , Glow Lifetech Ltd , Glow Lifetech Corp , Pharmaceuticals Ltd , Health Canada Natural , Newsfile Corp , Mycell Technology , Micelle Technology , Swiss Pharmacan Ag Micelle Technology , Health Canada , Health Products Directorate , Swiss Pharmacan , Chief Commercial Officer , Chief Operating Officer , Non Prescription Health Products Directorate , Once Health Canada , Natural Product Number , Relay Medical , ஒன்றுபட்டது மாநிலங்களில் , டப்ல்யூ கிளார்க் கேண்ட் , கொள்ளை கார்டுக்ஸி , பெர்ன்ஹார்ட் லாங்கர் ,

Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand

Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
Glow or the
Company ), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce the successful delivery of the first commercial production run of ArtemiC at its supply partner, Swiss PharmaCan AG ( SPC ) in April 2021
1, and a second production run worth nearly $1 million
2 CAD that is scaled to service the growing demand around the world.
Glow ArtemiC
https://orders.newsfilecorp.com/files/3920/82873 9c83b087946a5903 001full.jpg
Building on the Company s recent application to Health Canada for its natural oral spray, ArtemiC, following its successful COVID-19 Phase II clinical trial (see Glow s release dated April 27, 2021), the Company s strategic focus is on expediting the launch of ArtemiC in Canada and beyond as ....

United States , W Clark Kent , Rob Carducci , Tom Glawdel , Bernhard Langer , Glow Lifetech Ltd , Glow Lifetech Corp , Pharmaceuticals Ltd , Health Canada Natural , Newsfile Corp , Mycell Technology , Micelle Technology , Swiss Pharmacan Ag Micelle Technology , Health Canada , Health Products Directorate , Swiss Pharmacan , Chief Commercial Officer , Chief Operating Officer , Non Prescription Health Products Directorate , Once Health Canada , Natural Product Number , Relay Medical , ஒன்றுபட்டது மாநிலங்களில் , டப்ல்யூ கிளார்க் கேண்ட் , கொள்ளை கார்டுக்ஸி , பெர்ன்ஹார்ட் லாங்கர் ,

MGC Pharmaceuticals Ltd's North American distribution partner submits application to Health Canada for ArtemiC™

MGC Pharmaceuticals North American distribution partner submits application to Health Canada for ArtemiC™
Glow LifeTech has exclusive rights to market, sell and distribute ArtemiC™ in Canada, USA, Mexico and all Caribbean countries as a food supplement (nutraceutical, dietary supplement, natural health product).
The application included included ArtemiC™ supporting COVID-19 Phase II clinical trial results.
MGC Pharmaceuticals Ltd’s (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) Canadian-based development and North American distribution partner Glow LifeTech (CNSX:GLOW) (FRA:9DO) has submitted an application to Health Canada to obtain product licences for ArtemiC™ as a Natural Health Product (NHP).
ArtemiC™ was submitted to Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) on March 11, 2021. ....

United States , Roby Zomer , Rob Carducci , Health Canada Natural , Placebo Group , Health Canada , National Product Number , Natural Health Product , Health Products Directorate , North American , Glow Lifetech , Non Prescription Health Products Directorate , Natural Health , Tom Glawdel , Small Caps , Tc Markets Quoted , Mgc Pharmaceuticals Ltd , Lon Mxc , ஒன்றுபட்டது மாநிலங்களில் , ராபி ஜோமேற் , கொள்ளை கார்டுக்ஸி , ஆரோக்கியம் கனடா இயற்கை , மருந்துப்போலி குழு , ஆரோக்கியம் கனடா , இயற்கை ஆரோக்கியம் ப்ராடக்ட் , ஆரோக்கியம் ப்ராடக்ட்ஸ் இயக்குநரகம் ,